- Home
- NMTC vs DYAI Comparison
NMTC vs DYAI Comparison
Compare NMTC & DYAI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | NMTC | DYAI |
|---|---|---|
| Founded | 2009 | 1979 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Medical/Dental Instruments | Biotechnology: Biological Products (No Diagnostic Substances) |
| Sector | Health Care | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 31.5M | 29.9M |
| IPO Year | N/A | 2004 |
Fundamental Metrics
Financial Performance| Metric | NMTC | DYAI |
|---|---|---|
| Price | $0.91 | $0.89 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 2 | 1 |
| Target Price | $2.23 | ★ $3.00 |
| AVG Volume (30 Days) | ★ 392.8K | 81.2K |
| Earning Date | 02-11-2026 | 11-12-2025 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | ★ N/A | N/A |
| Revenue | ★ $12,097,692.00 | $3,342,195.00 |
| Revenue This Year | N/A | $12.52 |
| Revenue Next Year | $32.08 | $92.04 |
| P/E Ratio | N/A | N/A |
| Revenue Growth | ★ 250.35 | N/A |
| 52 Week Low | $0.40 | $0.71 |
| 52 Week High | $1.39 | $1.79 |
Technical Indicators
Market Signals| Indicator | NMTC | DYAI |
|---|---|---|
| Relative Strength Index (RSI) | 60.88 | 44.75 |
| Support Level | $0.86 | $0.84 |
| Resistance Level | $0.93 | $0.99 |
| Average True Range (ATR) | 0.07 | 0.06 |
| MACD | 0.01 | -0.00 |
| Stochastic Oscillator | 67.03 | 38.00 |
Price Performance
Historical ComparisonAbout NMTC NeuroOne Medical Technologies Corporation
NeuroOne Medical Technologies Corp operates as a medical technology company. It is focused on the development and commercialization of thin-film electrode technology for continuous electroencephalogram (cEEG) and stereoelectrocencephalography (sEEG) recording, brain stimulation, and ablation solutions for patients suffering from brain-related disorders. The company business is in one operating segment, which is the business of development and commercialization of products related to comprehensive neuromodulation cEEG and sEEG recording, monitoring, ablation, and brain stimulation solutions.
About DYAI Dyadic International Inc.
Dyadic International Inc is a worldwide biotechnology platform company. It has developed a gene expression platform for producing commercial quantities of industrial enzymes and other proteins and has licensed this technology to third parties, such as Abengoa Bioenergy, BASF, Codexis and others, for use in industrial (non-pharmaceutical) applications. This technology is based on the Thermothelomyces heterothallica fungus, which the company named C1.